AstraZeneca (NASDAQ:AZN) used its presentation at the J.P. Morgan Healthcare Conference to highlight strong 2025 performance, a growing late-stage pipeline, and management’s confidence in sustaining momentum through 2026 and toward its stated $80 billion revenue ambition for 2030.
2025 performance
Source link
Source : Wall Street Journal Source link
June 27, 2025June 27, 2025 Under the futures and options (F&O) segment, no stocks were banned from trade on Friday, 27 June, by the National Stock Exchange (NSE). Derivative contracts of these stocks were banned as the open market interest for these securities has crossed…
The Indian market ended lower on Friday, with benchmark indices Sensex and Nifty retreating from recent highs as investors turned defensive ahead of the Union Budget this weekend. By the end of the session, the benchmarks had pared some losses, with the Sensex down 296.59 points or 0.36% at 82,269.78, while the Nifty fell 98…
Bandai Namco Holdings Inc. – Unsponsored ADR (OTCMKTS:NCBDY – Get Free Report) was the target of a large growth in short interest in March. As of March 13th, there was short interest totaling 82,615 shares, a growth of 24.8% from the February 26th total of 66,179 shares. Currently, 0.0% of the company’s stock are sold…
November 15, 2024November 15, 2024 US markets continue to fall further as investors continue booking profits from the post-election rally. Moreover, the remarks from the Fed Chair, Jerome Powell, acted as a crucial trigger behind the market’s decline. S&P 500 and the Nasdaq Composite fell 0.6% each, while Dow…
Asian stocks crept higher following a sluggish session on Wall Street as investors awaited clues on the Federal Reserve’s policy path in its final interest-rate decision of the year. Benchmark share indexes in Japan and South Korea both gained, while US equity futures were little changed after the S&P 500 closed almost flat Tuesday. The…